Abstract
Proteinuria and hyperphosphatemia are risk factors for cardiovascular disease in patients with chronic kidney disease (CKD). Although the interaction between proteinuria and the serum phosphate level is well established, the mechanistic link between the two, particularly the extent to which this interaction is mediated by phosphate-regulating factors, remains poorly understood. In this study, we examined the association between proteinuria and the serum phosphate level, as well as potential mediators, including circulating fibroblast growth factor (FGF23)/klotho, the 24-h urinary phosphate excretion rate to glomerular filtration rate ratio (EP/GFR), and the 24-h tubular phosphate reabsorption rate to GFR ratio (TRP/GFR). The analyses were performed with data from 1793 patients in whom 24-h urine protein and phosphate, serum phosphate, FGF23, and klotho levels were measured simultaneously, obtained from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD). Multivariable linear regression and mediation analyses were performed. Total, direct, and indirect effects were also estimated. Patients with high serum phosphate levels were found to be more likely to exhibit greater proteinuria, higher FGF23 levels, and lower klotho levels. The 24-h EP/GFR increased and the 24-h TRP/GFR decreased with increasing proteinuria and CKD progression. Simple mediation analyses showed that 15.4% and 67.9% of the relationship between proteinuria and the serum phosphate level were mediated by the FGF23/klotho ratio and 24-h EP/GFR, respectively. Together, these two factors accounted for 73.1% of the relationship between serum markers. These findings suggest that proteinuria increases the 24-h EP/GFR via the FGF23/klotho axis as a compensatory mechanism for the increased phosphate burden well before the reduction in renal function is first seen.
Highlights
Patients with chronic kidney disease (CKD) exhibit significantly elevated rates of cardiovascular disease–related morbidity and mortality compared with the general population
This study presents noteworthy findings which may be useful in the pre-dialysis diagnosis of CKD
The degree of proteinuria correlated strongly with the serum fibroblast growth factor 23 (FGF23)/klotho ratio and 24-h excretion of phosphate (EP)/glomerular filtration rate (GFR), and these variables were related to the serum phosphate level
Summary
Patients with chronic kidney disease (CKD) exhibit significantly elevated rates of cardiovascular disease–related morbidity and mortality compared with the general population. Proteins that pass through the glomerular filtration barrier are captured in the proximal tubule and transferred to the systemic circulation; this process causes proteinuria in patients with glomerular damage [5, 6]. Phosphate serves as a buffer to help maintain normal serum levels as renal function decreases. As the glomerular filtration rate (GFR) decreases, the serum phosphate concentration is maintained within a normal range via the increased excretion of phosphate. Most of the phosphate that is filtered through the kidney is regulated by sodium and phosphate cotransporters 2a and 2c (NaPi-2a and NaPi-2c), located in the apical membrane of the renal proximal tubule, which is regulated by parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) [7]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
